BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 11997983)

  • 1. Gene therapy. Hidden X factor.
    Shamash J
    Nurs Times; 2002 Apr 16-22; 98(16):10. PubMed ID: 11997983
    [No Abstract]   [Full Text] [Related]  

  • 2. Gene therapy for XSCID: the first success of gene therapy.
    Kohn DB
    Pediatr Res; 2000 Nov; 48(5):578. PubMed ID: 11044472
    [No Abstract]   [Full Text] [Related]  

  • 3. [It is no more about cancer, but it is already about gene therapy].
    Jeanteur P
    Bull Cancer; 2000 Jun; 87(6):445-6. PubMed ID: 10928794
    [No Abstract]   [Full Text] [Related]  

  • 4. Partial immune reconstitution after bone marrow transplantation in a boy with recombination activating gene 1 defect.
    Muñoz-Robles J; Del Rey MJ; Ruiz-Contreras J; Clemente J; Ramos JT; Paz-Artal E; Allende LM
    Bone Marrow Transplant; 2004 Apr; 33(8):877-8. PubMed ID: 14990985
    [No Abstract]   [Full Text] [Related]  

  • 5. High-dose methylprednisolone is effective in the management of acute graft-versus-host disease in severe combined immune deficiency.
    Somech R; Kavadas FD; Atkinson A; Grunebaum E; Roifman CM
    J Allergy Clin Immunol; 2008 Dec; 122(6):1215-6. PubMed ID: 18672279
    [No Abstract]   [Full Text] [Related]  

  • 6. Gene therapy for immune disorders: good news tempered by bad news.
    Puck JM; Malech HL
    J Allergy Clin Immunol; 2006 Apr; 117(4):865-9. PubMed ID: 16630946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful transplantation of haploidentical CD34+ selected bone marrow cells for an infantile case of severe combined immunodeficiency with aspergillus pneumonia.
    Yoshihara T; Morimoto A; Nakauchi S; Fujii N; Tsunamoto K; Misawa A; Hibi S; Imashuku S
    Pediatr Hematol Oncol; 2002 Sep; 19(6):439-43. PubMed ID: 12186368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful pregnancy in a patient with severe combined immunodeficiency syndrome treated with bone marrow transplantation.
    Shrivastava VK; Arora N; Simpson EL; Wing DA
    Obstet Gynecol; 2008 Aug; 112(2 Pt 2):439-41. PubMed ID: 18669756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone marrow transplantation for cartilage-hair-hypoplasia.
    Guggenheim R; Somech R; Grunebaum E; Atkinson A; Roifman CM
    Bone Marrow Transplant; 2006 Dec; 38(11):751-6. PubMed ID: 17041608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. US panel advises resumption of gene trials.
    Fox JL
    Nat Biotechnol; 2002 Nov; 20(11):1068-9. PubMed ID: 12410240
    [No Abstract]   [Full Text] [Related]  

  • 11. Successful treatment of autoimmune hemolytic anemia with rituximab in a child with severe combined immunodeficiency following nonidentical T-cell-depleted bone marrow transplantation.
    Bonduel M; Zelazko M; Figueroa C; Magaldi G; Rossi J; del Pozo A
    Bone Marrow Transplant; 2005 Apr; 35(8):819-21. PubMed ID: 15750606
    [No Abstract]   [Full Text] [Related]  

  • 12. Gene therapy for severe combined immune deficiency.
    Qasim W; Gaspar HB; Thrasher AJ
    Expert Rev Mol Med; 2004 Jul; 6(13):1-15. PubMed ID: 15236670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment options for genetically determined immunodeficiency.
    Buckley RH
    Lancet; 2003 Feb; 361(9357):541-2. PubMed ID: 12598135
    [No Abstract]   [Full Text] [Related]  

  • 14. [Intensive care stay after a liver transplantation, a difficult step].
    Guerrini H; Evrard F
    Soins Pediatr Pueric; 2004 Feb; (216):30-1. PubMed ID: 15027254
    [No Abstract]   [Full Text] [Related]  

  • 15. [Gene therapy of severe combined immunodeficiency disease: proof of principle of efficiency and safety issues. Gene therapy, primary immunodeficiencies, retrovirus, lentivirus, genome].
    Fischer A; Hacein-Bey-Abina S; Lagresle C; Garrigue A; Cavazana-Calvo M
    Bull Acad Natl Med; 2005 May; 189(5):779-85; discussion 786-8. PubMed ID: 16433450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Successful gene therapy of children with severe immunodeficiency. Research breakthrough hopefully for the treatment of other diseases, too].
    Fasth A; Mellgren K; Karlsson S; Richter J
    Lakartidningen; 2002 Jul; 99(28-29):3010-2. PubMed ID: 12170507
    [No Abstract]   [Full Text] [Related]  

  • 17. French gene therapy group reports on the adverse event in a clinical trial of gene therapy for X-linked severe combined immune deficiency (X-SCID). Position statement from the European Society of Gene Therapy.
    European Society of Gene Therapy
    J Gene Med; 2003 Jan; 5(1):82-4. PubMed ID: 12516054
    [No Abstract]   [Full Text] [Related]  

  • 18. Long-term outcomes of nonconditioned patients with severe combined immunodeficiency transplanted with HLA-identical or haploidentical bone marrow depleted of T cells with anti-CD6 mAb.
    Patel NC; Chinen J; Rosenblatt HM; Hanson IC; Brown BS; Paul ME; Abramson SL; Ritz J; Shearer WT
    J Allergy Clin Immunol; 2008 Dec; 122(6):1185-93. PubMed ID: 19084111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What ongoing surveillance do you provide for patients post-transplant? Interview by Deborah Lindberg.
    Shergold J
    ONS Connect; 2012 Nov; 27(11):15. PubMed ID: 23316520
    [No Abstract]   [Full Text] [Related]  

  • 20. Combined autologous cellular cardiomyoplasty with skeletal myoblasts and bone marrow cells in canine hearts for ischemic cardiomyopathy.
    Memon IA; Sawa Y; Miyagawa S; Taketani S; Matsuda H
    J Thorac Cardiovasc Surg; 2005 Sep; 130(3):646-53. PubMed ID: 16153908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.